Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary

Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary

Objective: Major depressive disorder (MDD) is a significant public health concern and challenges health care providers to intervene with appropriate treatment. This article provides an overview of efficacy and safety information for duloxetine 60 mg/day in the treatment of MDD, including its effect...

Full description

Bibliographic Details
Main Authors:	Susan G Ball, Durisala Desaiah, Qi Zhang, Michael E Thase, David GS Perahia
Format:	Article
Language:	English
Published:	BioExcel Publishing Ltd 2013-01-01
Series:	Drugs in Context
Subjects:	duloxetine major depressive disorder painful physical symptoms quality of life effect size safety and tolerability
Online Access:	http://drugsincontext.com/individual/efficacy-and-safety-of-duloxetine-60-mg-once-daily-in-depressive-disorder

Similar Items

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
by: Harada E, et al.
Published: (2016-01-01)

Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy
by: Kuga A, et al.
Published: (2019-04-01)

Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
by: Maneeton B, et al.
Published: (2018-08-01)

Early reduction in painful physical symptoms is associated with improvements in long-term depression outcomes in patients treated with duloxetine
by: Quail Deborah, et al.
Published: (2011-09-01)

Duloxetine-induced Sleep Bruxism in Fibromyalgia Successfully Treated With Amitriptyline
by: Şule Şahin Onat, et al.
Published: (2015-10-01)

Tumor growth activity of duloxetine in Ehrlich carcinoma in mice
by: Ed Carlos Rey Moura, et al.
Published: (2018-07-01)

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
by: Novick D, et al.
Published: (2016-02-01)

Role of Duloxetine in management of cervical or lumbosacral neuralgia of unknown etiology: A preliminary study
by: Digambar P Nawani, et al.
Published: (2013-01-01)

The Effect of Preoperative Administration of Duloxetine on Postoperative Pain After Laparoscopic Myomectomy
by: Maryam Hatami, et al.
Published: (2020-07-01)

Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: A double-blind controlled study
by: Hamed Daghaghzadeh, et al.
Published: (2015-01-01)

Comparison of duloxetine and SSRI as a treatment option of painful physical symptoms associated with major depressive disorder
by: Haider M, et al.
Published: (2017-10-01)

Duloxetine-induced hyponatraemia in a patient with hypocortisolaemia
by: Mayuko Ikeguchi, et al.
Published: (2020-01-01)

Update on duloxetine for the management of stress urinary incontinence
by: Maya Basu, et al.
Published: (2008-11-01)

Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
by: Russell J, et al.
Published: (2010-01-01)

Duloxetine and pregabalin in neuropathic pain of lung cancer patients
by: Şule Karabulut Gül, et al.
Published: (2020-03-01)

A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine
by: Daniela Rodrigues-Amorim, et al.
Published: (2020-10-01)

Reversible cycloplegia caused by duloxetine: a case report
by: Rabia Nazik Yüksel, et al.
Published: (2017-07-01)

A Quasi-Experimental Trial in Comparison of Duloxetine and Methylphenidate in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder
by: Nasrin Dodangi, et al.
Published: (2016-06-01)

An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis
by: Kuga A, et al.
Published: (2017-08-01)

Bleeding gums: Duloxetine may be the cause
by: Balhara YPS, et al.
Published: (2007-01-01)

A Real-World, Prospective, Multicenter, Single-Arm Observational Study of Duloxetine in Patients With Major Depressive Disorder or Generalized Anxiety Disorder
by: Gyorgy Szekeres, et al.
Published: (2021-06-01)

Effect of duloxetine on neuropathic pain in patients intolerant to continuous administration of pregabalin
by: Yohei Shimada, et al.
Published: (2017-01-01)

Study of Sex Differences in Duloxetine Efficacy for Depression in Transgenic Mouse Models
by: Yong Xu, et al.
Published: (2017-10-01)

Efficacy of Epalrestat, Duloxetine and Epalrestat in Combination with Methylcobalamine in Diabetic Peripheral Neuropathy
by: Abhilash Penchala, et al.
Published: (2016-12-01)

Comparing the efficacy and safety of duloxetine and amitriptyline in the treatment of fibromyalgia: overview of systematic reviews
by: Áurea Dias de Farias, et al.
Published: (2020-07-01)

Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data
by: Guochun Wang, et al.
Published: (2019-04-01)

Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis
by: Mikala C. Osani, et al.
Published: (2019-09-01)

Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials
by: Alev L, et al.
Published: (2017-07-01)

The effect of pregabalin or duloxetine on arthritis pain: a clinical and mechanistic study in people with hand osteoarthritis
by: Sofat N, et al.
Published: (2017-10-01)

Duloxetine reduces pain after Total hip arthroplasty: a prospective, randomized controlled study
by: Hao Li, et al.
Published: (2021-05-01)

Investigation the effectiveness of duloxetine in quality of life and symptoms of patients with irritable bowel syndrome
by: Razieh Salehian, et al.
Published: (2021-01-01)

A comparative double-blind randomized study on the effectiveness of Duloxetine and Gabapentin on painful diabetic peripheral polyneuropathy
by: Majdinasab N, et al.
Published: (2019-06-01)

Atomoxetine and Duloxetine: Evaluation of a Potential Pharmacokinetic Drug-Drug Interaction
by: Todor Ioana, et al.
Published: (2019-12-01)

Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder
by: Maria Rosaria Anna Muscatello, et al.
Published: (2019-10-01)

Auditory, visual and tactile hallucinations in a 16-year-old adolescent with high-dose duloxetine at one time
by: Sefa Cosgun
Published: (2020-01-01)

Saffron (Crocus sativus) versus duloxetine for treatment of patients with fibromyalgia: A randomized double-blind clinical trial
by: Mansoor Shakiba, et al.
Published: (2018-11-01)

Impact of duloxetine and dexamethasone for improving postoperative pain after laparoscopic gynecological surgeries: A randomized clinical trial
by: Dina Y Kassim, et al.
Published: (2018-01-01)

Duloxetine versus ‘active’ placebo, placebo or no intervention for major depressive disorder; a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis
by: Faiza Siddiqui, et al.
Published: (2021-06-01)

Visual hallucination induced by duloxetine use: a male case diagnosed with generalized anxiety disorder
by: Kemal Utku Yazici, et al.
Published: (2018-07-01)

Preparation and evaluation of duloxetine hydrochloride enteric-coated pellets with different enteric polymers
by: Chen Kuang, et al.
Published: (2017-05-01)